Literature DB >> 28933656

Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.

Jonathan C Hagopian1, Alexander S Hamil1, Arjen van den Berg1, Bryan R Meade1, Akiko Eguchi1, Caroline Palm-Apergi1, Steven F Dowdy1.   

Abstract

Small double-stranded, left-handed hairpin (LHP) RNAs containing a 5'-guide-loop-passenger-3' structure induce RNAi responses by a poorly understood mechanism. To explore LHPs, we synthesized fully 2'-modified LHP RNAs targeting multiple genes and found all to induce robust RNAi responses. Deletion of the loop and nucleotides at the 5'-end of the equivalent passenger strand resulted in a smaller LHP that still induced strong RNAi responses. Surprisingly, progressive deletion of up to 10 nucleotides from the 3'-end of the guide strand resulted in a 32mer LHP capable of inducing robust RNAi responses. However, further guide strand deletion inhibited LHP activity, thereby defining the minimal length guide targeting length to 13 nucleotides. To dissect LHP processing, we examined LHP species that coimmunoprecipitated with Argonaute 2 (Ago2), the catalytic core of RNA-induced silencing complex, and found that the Ago2-associated processed LHP species was of a length that correlated with Ago2 cleavage of the passenger strand. Placement of a blocking 2'-OMe blocking modification at the LHP predicted Ago2 cleavage site resulted in an intact LHP loaded into Ago2 and no RNAi response. Taken together, these data argue that in the absence of a substantial loop, this novel class of small LHP RNAs enters the RNAi pathway by a Dicer-independent mechanism that involves Ago2 cleavage and results in an extended guide strand. This work establishes LHPs as an alternative RNAi trigger that can be produced from a single synthesis for potential use as an RNAi therapeutic.

Entities:  

Keywords:  RNAi responses; RNAi triggers; left-handed hairpin RNA

Mesh:

Substances:

Year:  2017        PMID: 28933656      PMCID: PMC5649124          DOI: 10.1089/nat.2017.0686

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  34 in total

1.  Gene silencing using micro-RNA designed hairpins.

Authors:  Michael T McManus; Christian P Petersen; Brian B Haines; Jianzhu Chen; Phillip A Sharp
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

Review 2.  Chemical modification of siRNAs for in vivo use.

Authors:  Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-12

3.  Potent RNAi by short RNA triggers.

Authors:  Chia-Ying Chu; Tariq M Rana
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.

Authors:  Bryan R Meade; Khirud Gogoi; Alexander S Hamil; Caroline Palm-Apergi; Arjen van den Berg; Jonathan C Hagopian; Aaron D Springer; Akiko Eguchi; Apollo D Kacsinta; Connor F Dowdy; Asaf Presente; Peter Lönn; Manuel Kaulich; Naohisa Yoshioka; Edwige Gros; Xian-Shu Cui; Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

6.  RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients.

Authors:  Iryna Kolosenko; Elin Edsbäcker; Ann-Charlotte Björklund; Alexander S Hamil; Oksana Goroshchuk; Dan Grandér; Steven F Dowdy; Caroline Palm-Apergi
Journal:  J Control Release       Date:  2017-07-03       Impact factor: 9.776

Review 7.  Modelling the molecular circuitry of cancer.

Authors:  William C Hahn; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

8.  Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis.

Authors:  Jr-Shiuan Yang; Thomas Maurin; Nicolas Robine; Kasper D Rasmussen; Kate L Jeffrey; Rohit Chandwani; Eirini P Papapetrou; Michel Sadelain; Dónal O'Carroll; Eric C Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-10       Impact factor: 11.205

9.  Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Authors:  Qing Ge; Anne Dallas; Heini Ilves; Joshua Shorenstein; Mark A Behlke; Brian H Johnston
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

10.  Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.

Authors:  Jens Harborth; Sayda M Elbashir; Kim Vandenburgh; Heiko Manninga; Stephen A Scaringe; Klaus Weber; Thomas Tuschl
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2003-04
View more
  1 in total

Review 1.  GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Authors:  Aaron D Springer; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2018-05-24       Impact factor: 5.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.